$788.61
10.43[1.34%]
Last update: 10:47AM Get Real Time Here
Eli Lilly and Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eli Lilly and Co using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | AM | LLY | Q1 | $1.62 | $2.52 | — | — | $6.96B | $8.99B | — | — | Get Alert |
02/06/2024 | AM | LLY | Q4 | $2.09 | $2.19 | $2.49 | 13.70% | $7.30B | $8.93B | $9.35B | 4.74% | Get Alert |
11/02/2023 | AM | LLY | Q3 | $1.98 | -$0.15 | $0.10 | 166.67% | $6.94B | $8.95B | $9.50B | 6.13% | Get Alert |
08/08/2023 | AM | LLY | Q2 | $1.25 | $1.99 | $2.11 | 6.03% | $6.49B | $7.58B | $8.31B | 9.66% | Get Alert |
04/27/2023 | AM | LLY | Q1 | $2.62 | $1.73 | $1.62 | -6.36% | $7.81B | $6.86B | $6.96B | 1.46% | Get Alert |
02/02/2023 | AM | LLY | Q4 | $2.49 | $1.78 | $2.09 | 17.42% | $8.00B | $7.33B | $7.30B | -0.38% | Get Alert |
11/01/2022 | AM | LLY | Q3 | $1.77 | $1.92 | $1.98 | 3.12% | $6.77B | $6.91B | $6.94B | 0.46% | Get Alert |
08/04/2022 | AM | LLY | Q2 | $1.87 | $1.69 | $1.25 | -26.04% | $6.74B | $6.70B | $6.49B | -3.16% | Get Alert |
04/28/2022 | AM | LLY | Q1 | $1.87 | $2.13 | $2.62 | 23.00% | $6.81B | $6.68B | $7.81B | 16.92% | Get Alert |
02/03/2022 | AM | LLY | Q4 | $2.75 | $2.19 | $2.49 | 13.70% | $7.44B | $6.90B | $8.00B | 15.94% | Get Alert |
10/26/2021 | AM | LLY | Q3 | $1.54 | $1.68 | $1.94 | 15.48% | $5.74B | $5.70B | $6.77B | 18.82% | Get Alert |
08/03/2021 | AM | LLY | Q2 | $1.89 | $1.92 | $1.87 | -2.60% | $5.50B | $6.65B | $6.74B | 1.35% | Get Alert |
04/27/2021 | AM | LLY | Q1 | $1.75 | $2.14 | $1.87 | -12.62% | $5.86B | $7.02B | $6.81B | -3.05% | Get Alert |
01/29/2021 | AM | LLY | Q4 | $1.73 | $2.35 | $2.75 | 17.02% | $6.11B | $7.29B | $7.44B | 2.06% | Get Alert |
10/27/2020 | AM | LLY | Q3 | $1.48 | $1.71 | $1.54 | -9.94% | $5.48B | $5.91B | $5.74B | -2.86% | Get Alert |
07/30/2020 | AM | LLY | Q2 | $1.50 | $1.56 | $1.89 | 21.15% | $5.64B | $5.76B | $5.50B | -4.53% | Get Alert |
04/23/2020 | AM | LLY | Q1 | $1.33 | $1.48 | $1.75 | 18.24% | $5.09B | $5.51B | $5.86B | 6.35% | Get Alert |
01/30/2020 | AM | LLY | Q4 | $1.33 | $1.51 | $1.73 | 14.57% | $6.44B | $5.90B | $6.11B | 3.63% | Get Alert |
10/23/2019 | AM | LLY | Q3 | $1.39 | $1.40 | $1.48 | 5.71% | $6.06B | $5.50B | $5.48B | -0.42% | Get Alert |
Eli Lilly and Co (LLY) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on February 6, 2024 for Q4.
The Actual EPS was $2.49, which beat the estimate of $2.19.
The Actual Revenue was $9.4B, which beat the estimate of $8.9B.
Browse earnings estimates, EPS, and revenue on all stocks.